Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.
CNN reports that researchers have tied a new variant to opioid addiction risk.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Prescient Medicine says its genetic test can identify people who may be at a higher risk of developing an opioid addiction, Fast Company reports.
The university is marshaling the expertise across all its schools in studying myriad factors that might contribute to opioid response, addiction, and abuse.
The company joins others in a still-controversial setting, hoping to market its test to help guide the prescription of narcotic pain medications.
Proove Biosciences responds to its visit by federal investigators and concerns surrounding its tests and business approaches.
Federal investigators have searched the offices of Proove Biosciences, Stat News reports.
The Philadelphia Inquirer writes that a genetic test to gauge opioid abuse risk might not work.
A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.
In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.
CNBC reports that half of academic researchers leave after about five years.
Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.